This research investigates the role of estrogen in working memory and language comprehension in healthy elderly women (65-85 years old) and women who have been diagnosed with probably Alzheimer's Disease (AD). Recent research has shown an important link between estrogen and working memory and cognitive functioning within elderly normal and demented women, in that women receiving postmenopausal estrogen replacement therapy (ERT) have higher scores on certain cognitive and memory tests than do women without ERT. There has been only a limited investigation of whether ERT affects language functions, and most evidence has not supported a large role for ERT in language abilities, particularly in the healthy, non-demented women. However, most studies have not tested language abilities that are known to rely heavily on working memory capacity. A major hypothesis of the proposed research is that ERT does have a large effect working memory and on language comprehension processes that depend on working memory. New sensitive language and working memory measures developed by the PIs are predicted reveal this relationship. The research involves a novel combination of behavioral tests and functional magnetic resonance imaging (fMRI). Seventy-two women (36 normal elderly, 36 AD patients, half in each group currently receiving ERT) will be tested on an extensive battery of working memory tests and on language comprehension tests that are known to rely on working memory. All normal participants and some AD participants will receive fMRI scans while performing sensitive working memory tests. The combination of memory, language, and imaging data will illuminate the relationship between estrogen, working memory, language comprehension, and dementia.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
3P50AG005142-16S1
Application #
6295393
Study Section
Project Start
1999-04-01
Project End
2000-03-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
16
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Wang, Qi; Guo, Lei; Thompson, Paul M et al. (2018) The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1. J Alzheimers Dis 64:149-169
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487
Aydogan, Dogu Baran; Jacobs, Russell; Dulawa, Stephanie et al. (2018) When tractography meets tracer injections: a systematic study of trends and variation sources of diffusion-based connectivity. Brain Struct Funct 223:2841-2858
Gahm, Jin Kyu; Shi, Yonggang; Alzheimer’s Disease Neuroimaging Initiative (2018) Riemannian metric optimization on surfaces (RMOS) for intrinsic brain mapping in the Laplace-Beltrami embedding space. Med Image Anal 46:189-201
Emrani, Sheina; Libon, David J; Lamar, Melissa et al. (2018) Assessing Working Memory in Mild Cognitive Impairment with Serial Order Recall. J Alzheimers Dis 61:917-928
Hernandez, Gerson; Zhao, Liqin; Franke, Adrian A et al. (2018) Pharmacokinetics and safety profile of single-dose administration of an estrogen receptor ?-selective phytoestrogenic (phytoSERM) formulation in perimenopausal and postmenopausal women. Menopause 25:191-196
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Ho, Jean K; Nation, Daniel A; Alzheimer’s Disease Neuroimaging Initiative (2018) Neuropsychological Profiles and Trajectories in Preclinical Alzheimer's Disease. J Int Neuropsychol Soc 24:693-702

Showing the most recent 10 out of 590 publications